Michael B. Atkins
Board Member
Werewolf Therapeutics, Inc. (HOWL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael B. Atkins
Michael B. Atkins is recorded as Board Member at Werewolf Therapeutics, Inc. (HOWL). Werewolf Therapeutics, Inc. reported in an 8-K filed January 4, 2024 that Michael B. Atkins was appointed director, effective January 4, 2024.
“On January 4, 2024, the Board of Directors (the "Board") of Werewolf Therapeutics, Inc. (the "Company"), upon recommendation of the Board's Nominating and Corporate Governance Committee, appointed Michael B. Atkins, M.D., as a director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Werewolf Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel J. Hicklin CEO, Board Member
- Michael Urban CFO
- Reid Leonard COO
- Chulani Karunatilake CTO
- Anil Singhal, Ph.D. Board Member
- Meeta Chatterjee, Ph.D. Board Member
- Michael A. Sherman Board Member
- Michael B. Atkins, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.